The archive
Every article,
from most recent.
News, buyer's guides, original research, and opinion — everything we've published on consumer whole genome sequencing. The home page shows the four most recent; this is the full archive.
- Veritas Genetics joins Illumina consortium to put WGS inside health insurance plansRead →
- Utah and South Dakota enacted genetic privacy laws in 2026, but gaps remainRead →
- The four categories of WGS in 2026, and why you should care which one you're buyingRead →
- Nucleus Genomics: the post-Nebula frontrunner, and the IVF positioning it keeps stepping onRead →
- Coverage depth, explained: why 30× isn't the ceiling — and when 1× is enoughRead →
- Nebula Genomics is gone. DNA Complete is the successor. Here's what Nebula subscribers should do.Read →
- Long-read sequencing dips below $1,000, but not where you need itRead →
- Polygenic risk scores are not diagnoses. Stop selling them like they are.Read →
- Veritas myGenome: the clinician-mediated preventive WGS, with the prescription wallRead →
- Dante Labs promised 8 weeks. We timed twelve orders across 2025. Median was 6 months.Read →
- What actually happens to your spit between Day 1 and Day 60Read →
© 2026 Genome Reviews · ISSN 2769-4102 · Press T to toggle Journal ↔ Terminal